Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus – (Eye 30, 825 (June 2016))
Glucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus Eye 30, 825 (June 2016). doi:10.1038/eye.2016.48 Authors: M S Stem, G E Dunbar, G R Jackson, S Farsiu, R Pop-Busui & T W Gardner
Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma – (Eye 30, 833 (June 2016))
Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma Eye 30, 833 (June 2016). doi:10.1038/eye.2016.49 Authors: J M Caminal, N Padrón-Pérez, L Arias, C Masuet-Aumatell, C Gutiérrez, J M Piulats, J Pera, J Català, M J Rubio & J Arruga
Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma – (Eye 30, 843 (June 2016))
Intravitreal bevacizumab monotherapy for choroidal neovascularisation secondary to choroidal osteoma Eye 30, 843 (June 2016). doi:10.1038/eye.2016.50 Authors: V P Papastefanou, M Pefkianaki, L Al Harby, A K Arora, V M L Cohen, R M Andrews & M S Sagoo
Finasteride is effective for the treatment of central serous chorioretinopathy – (Eye 30, 850 (June 2016))
Finasteride is effective for the treatment of central serous chorioretinopathy Eye 30, 850 (June 2016). doi:10.1038/eye.2016.53 Authors: E Moisseiev, A J Holmes, A Moshiri & L S Morse
The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren’s syndrome: a pilot study – (Eye 30, 857 (June 2016))
The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren’s syndrome: a pilot study Eye 30, 857 (June 2016). doi:10.1038/eye.2016.54 Authors: N Yokoi, H Kato & S Kinoshita